Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers

Author(s):  Zur Eyal

Issue:  Nov/Dec 2011 - Volume 15, Number 6
View All Articles in Issue

Page(s):  458-463

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 1
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 2
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 3
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 4
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 5
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 6

Download in electronic PDF format for $75

Abstract:  Part 2 of a 2-part article about infantile hemangiomas, the most common benign tumors of infancy, was published previously in the International Journal of Pharmaceutical Compounding. Part 1 provided a comprehensive discussion about infantile hemangiomas, the current accumulative knowledge in the treatment of this pathology, and the use of oral propranolol in the treatment of infantile hemangiomas. This article continues that discussion but focuses on the topical treatment of this pathology.

Related Keywords: Eyal Zur, RPh, MBA, formulations, infantile hemangioma, infants, steroids, corticosteroids, immune response modifiers, beta blockers, topical preparations, literature review, iontophoresis, propranolol hydrochloride, skin permeability, percutaneous absorption

Related Categories: CANCER AND AIDS, DERMATOLOGY, FORMULATIONS, PEDIATRICS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
Sep/Oct 2011
Pg. 358-366

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Basics of Compounding for Iontophoresis, Part II
Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292

Treatment Options for Psoriasis
Williams LaVonn A
, Humphreys Erica
May/Jun 2011
Pg. 204-213

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Zur Eyal
Nov/Dec 2018
Pg. 446-454

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
Jul/Aug 2012
Pg. 288-293

Return to Top